Home
Conditions
Carcinoma in Situ

Clinical trial condition

Carcinoma in Situ

Explore clinical trials studying Carcinoma in Situ. Study availability and eligibility vary by location and protocol.

304 public trials 54 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma in Situ trial results

Recruiting

Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT)

NCT04985032

Conditions: Adenocarcinoma, Breast Carcinoma In Situ, Carcinoma, +8 more
Locations: CyberKnife Center of South Florida in Stuart Stuart, Florida, United States

CyberKnife Centers of Tampa Bay Tampa, Florida, United States

View Trial Details

Recruiting

Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ

NCT04666961

Conditions: Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +14 more
Locations: ICO - Site Paul Papin Angers, France

Institut Bergonie Bordeaux, France

Institut de cancérologie de Montpellier Montpellier, France

Centre Antoine Lacassagne Nice, France

View Trial Details

Recruiting

A Registry Study of Breast Microseed Treatment

NCT02701244

Conditions: Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +11 more
Locations: Allegheny General Hospital Pittsburgh, Pennsylvania, United States

Mary Washington Hospital Fredericksburg, Virginia, United States

Swedish Cancer Institute Seattle, Washington, United States

View Trial Details

Recruiting

Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy

NCT01185132

Conditions: Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +12 more
Locations: Rocky Mountain Cancer Centers - Aurora Aurora, Colorado, United States

Rocky Mountain Cancer Centers - Boulder Boulder, Colorado, United States

Rocky Mountain Cancer Centers - Lakewood Lakewood, Colorado, United States

Rocky Mountain Cancer Centers - Littleton Littleton, Colorado, United States

View Trial Details

Enrolling by Invitation

Trastuzumab Plus Taxane Neoadjuvant Therapy for HER2-Positive Breast Ductal Carcinoma In Situ (DCIS) : A Phase II Study

NCT06843681

Conditions: Breast Carcinoma In Situ, Breast Carcinoma in Situ, Breast Diseases, +9 more
Locations: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

CAN1012 in Pre-Malignant DCIS and LCIS

NCT07408856

Conditions: Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +13 more
Locations: Providence Portland Cancer Institute - Franz Clinic Portland, Oregon, United States

View Trial Details

Not Yet Recruiting

A Navigation Program to Improve Survivorship Support Service Participation Among Non-metastatic Breast Cancer Survivors

NCT07699991

Conditions: Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, +13 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Not Yet Recruiting

Assessment of Biosignature Classification of DCIS for RadioTherapy Benefit Post Lumpectomy (ABCD RT)

NCT07554573

Conditions: Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Areola Preservation in NSM With Nipple Involvement

NCT07544134

Conditions: Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +14 more
Locations: The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Not Yet Recruiting

HISMAR: Intraoperative Margin Assessment Using the Histolog® Scanner to Reduce Reoperation in Breast-Conserving Surgery

NCT07527468

Conditions: Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +19 more
Locations: Centre Hospitalier du Valais Romand (CHVR) Sion, Valais, Switzerland

View Trial Details

Carcinoma in Situ

Carcinoma in Situ trial results

Related conditions